First European randomized trial of PCI vs. optimized medical therapy in CTO

(PCR) EuroPCR 2017, Paris, France: Revascularization with percutaneous coronary intervention (PCI) achieves a high success rate with low procedural risk in patients with coronary chronic total occlusion, show results reported at EuroPCR 2017 from the first European randomized trial to compare PCI with optimized medical therapy in this group of patients.